New study co-led by OHSU researchers provides most robust U.S. estimate to date, shows overdiagnosis not as ‘alarmingly frequent’ as commonly believed.
The use of a “race factor” in clinical algorithms that help determine who gets what treatments for various diseases in under scrutiny; its removal in the algorithm for kidney disease follows national recommendations championed locally.